SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-09-007787
Filing Date
2009-11-05
Accepted
2009-11-05 16:43:28
Documents
22
Period of Report
2009-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARMACEUTICALS INCORPORATED 8-K a6092591.htm 8-K 18749
2 EXHIBIT 99.1 a6092591ex99_1.htm EX-99.1 87913
3 EXHIBIT 99.2 a6092591ex99_2.htm EX-99.2 24050
4 SLIDE 1 slide1.jpg GRAPHIC 48074
5 slide2.jpg GRAPHIC 161534
6 slide3.jpg GRAPHIC 223892
7 slide4.jpg GRAPHIC 22792
8 slide5.jpg GRAPHIC 91900
9 slide6.jpg GRAPHIC 94877
10 slide7.jpg GRAPHIC 71095
11 slide8.jpg GRAPHIC 62419
12 slide9.jpg GRAPHIC 91299
13 SLIDE 10 slide10.jpg GRAPHIC 68640
14 slide11.jpg GRAPHIC 60521
15 slide12.jpg GRAPHIC 71783
16 slide13.jpg GRAPHIC 61082
17 slide14.jpg GRAPHIC 21808
18 slide15.jpg GRAPHIC 128647
19 slide16.jpg GRAPHIC 97651
20 slide17.jpg GRAPHIC 121668
21 slide18.jpg GRAPHIC 119677
22 slide19.jpg GRAPHIC 89066
  Complete submission text file 0001157523-09-007787.txt   2488330
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 091161662
SIC: 2834 Pharmaceutical Preparations